Free Trial

Allianz Asset Management GmbH Purchases 5,748 Shares of The Clorox Company (NYSE:CLX)

Clorox logo with Consumer Staples background

Key Points

  • Allianz Asset Management GmbH increased its stake in The Clorox Company by 33.3% in the first quarter, bringing its total to 23,007 shares worth approximately $3.39 million.
  • Clorox reported $1.45 earnings per share for the recent quarter, missing estimates, with revenue down 8.0% year-over-year at $1.67 billion.
  • Most analysts have a consensus rating of "Hold" on Clorox stock, with target prices ranging from $119 to $144.83.
  • Looking to export and analyze Clorox data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Allianz Asset Management GmbH increased its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 33.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 23,007 shares of the company's stock after acquiring an additional 5,748 shares during the quarter. Allianz Asset Management GmbH's holdings in Clorox were worth $3,388,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in CLX. American Century Companies Inc. grew its holdings in Clorox by 17.9% in the 4th quarter. American Century Companies Inc. now owns 76,400 shares of the company's stock valued at $12,408,000 after buying an additional 11,606 shares in the last quarter. Blair William & Co. IL grew its holdings in Clorox by 1.2% in the 4th quarter. Blair William & Co. IL now owns 9,271 shares of the company's stock valued at $1,506,000 after buying an additional 107 shares in the last quarter. Pictet Asset Management Holding SA grew its holdings in Clorox by 2.5% in the 4th quarter. Pictet Asset Management Holding SA now owns 74,605 shares of the company's stock valued at $12,117,000 after buying an additional 1,787 shares in the last quarter. Allstate Corp acquired a new position in Clorox in the 4th quarter valued at $605,000. Finally, California Public Employees Retirement System grew its holdings in Clorox by 1.3% in the 4th quarter. California Public Employees Retirement System now owns 565,810 shares of the company's stock valued at $91,893,000 after buying an additional 6,987 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Price Performance

NYSE:CLX traded down $2.50 during trading hours on Friday, hitting $123.06. The company's stock had a trading volume of 3,928,421 shares, compared to its average volume of 1,666,065. The stock has a fifty day simple moving average of $126.07 and a 200-day simple moving average of $139.01. The company has a market capitalization of $15.17 billion, a P/E ratio of 18.87, a PEG ratio of 3.46 and a beta of 0.49. The company has a debt-to-equity ratio of 13.07, a current ratio of 0.74 and a quick ratio of 0.44. The Clorox Company has a twelve month low of $117.35 and a twelve month high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.63. The business had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.94 billion. Clorox had a return on equity of 538.72% and a net margin of 11.40%. Clorox's revenue was up 4.5% compared to the same quarter last year. During the same period last year, the firm posted $1.82 earnings per share. On average, analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 29th. Investors of record on Wednesday, August 13th will be paid a $1.24 dividend. This represents a $4.96 annualized dividend and a yield of 4.0%. This is a boost from Clorox's previous quarterly dividend of $1.22. The ex-dividend date of this dividend is Wednesday, August 13th. Clorox's payout ratio is 76.07%.

Analyst Ratings Changes

CLX has been the topic of a number of research reports. Citigroup reaffirmed a "neutral" rating and issued a $135.00 price objective (down from $140.00) on shares of Clorox in a report on Tuesday, July 15th. UBS Group reduced their target price on Clorox from $150.00 to $134.00 and set a "neutral" rating on the stock in a report on Thursday, July 17th. Wells Fargo & Company increased their target price on Clorox from $135.00 to $138.00 and gave the stock an "equal weight" rating in a report on Friday. Jefferies Financial Group reduced their target price on Clorox from $167.00 to $145.00 and set a "buy" rating on the stock in a report on Thursday, June 26th. Finally, Barclays reduced their target price on Clorox from $129.00 to $119.00 and set an "underweight" rating on the stock in a report on Tuesday, July 15th. Three investment analysts have rated the stock with a sell rating, nine have issued a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $143.36.

Read Our Latest Analysis on Clorox

Insiders Place Their Bets

In other news, Director Pierre R. Breber bought 4,000 shares of the company's stock in a transaction on Wednesday, May 7th. The stock was purchased at an average cost of $136.57 per share, for a total transaction of $546,280.00. Following the completion of the transaction, the director owned 4,000 shares of the company's stock, valued at $546,280. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available at this link. 0.57% of the stock is owned by company insiders.

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Read More

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: All Signs Point to More Growth Ahead
3 Quiet Growth Stocks With Major Momentum
The Market’s Next Big Winners? Start Here

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines